CHRONIC HEPATITIS C
Clinical trials for CHRONIC HEPATITIS C explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS C trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cholesterol drug and a bile acid pill help reverse liver scarring?
Disease control TerminatedThis pilot study tests whether simvastatin (a cholesterol-lowering drug) and ursodeoxycholic acid (a bile acid medication), taken alone or together for six months, can improve markers of liver fibrosis in adults with advanced liver scarring after viral hepatitis has been controll…
Matched conditions: CHRONIC HEPATITIS C
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Hepatitis c blood study halted early: what it means
Knowledge-focused TerminatedThis study aimed to see how often people with chronic hepatitis C have a blood condition called monoclonal B-cell lymphocytosis (MBL), and whether treating hepatitis C affects MBL. Researchers planned to enroll 29 participants and compare blood samples before and after hepatitis …
Matched conditions: CHRONIC HEPATITIS C
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC